Advanced Cancers: AD-O51.4 Safety Study

We are evaluating the safety of a new investigational drug called AD-O51.4 for patients with advanced malignancies. This study aims to understand how well the drug is tolerated in this patient group.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie
Oddział Onkologii Klinicznej
Kraków, Poland
Umed Clinical Trials Sp. z o.o.
Klinika Onkologii Klinicznej
Łódź, Poland
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Klinika Nowotworów Tkanek Miękkich, Kości i Czerniaków / Oddział Badań Wczesnych Faz
Ursynów, Poland

Sponsor: Adamed Pharma S.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.